Shenzhen - Delayed Quote CNY

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ)

36.88 -0.52 (-1.39%)
At close: 3:03 PM GMT+8
Loading Chart for 002223.SZ
DELL
  • Previous Close 37.40
  • Open 36.09
  • Bid 36.87 x --
  • Ask 36.88 x --
  • Day's Range 36.38 - 37.35
  • 52 Week Range 29.66 - 38.03
  • Volume 9,023,522
  • Avg. Volume 8,786,736
  • Market Cap (intraday) 36.971B
  • Beta (5Y Monthly) 0.03
  • PE Ratio (TTM) 13.76
  • EPS (TTM) 2.68
  • Earnings Date --
  • Forward Dividend & Yield 0.60 (1.60%)
  • Ex-Dividend Date May 29, 2023
  • 1y Target Est 44.45

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. engages in the manufacture and sale of medical devices in China and internationally. The company offers respiratory solutions, including single and bi-level PAP, breathwear masks, oxygen concentrators, high flow nasal cannula oxygen therapy, nebulizers, and suction apparatus; blood pressure and glucose systems; infrared, infrared ear, and medical digital thermometers; oximeters; and wheelchairs and electric wheelchairs. The company was formerly known as Yuwell medical. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. was founded in 1998 and is based in Danyang, China.

www.yuyue.com.cn

6,362

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 002223.SZ

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

002223.SZ
6.65%
SSE Composite Index
2.35%

1-Year Return

002223.SZ
23.46%
SSE Composite Index
7.77%

3-Year Return

002223.SZ
38.86%
SSE Composite Index
12.36%

5-Year Return

002223.SZ
63.96%
SSE Composite Index
4.81%

Compare To: 002223.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002223.SZ

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    37.49B

  • Enterprise Value

    31.68B

  • Trailing P/E

    13.94

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.26

  • Price/Book (mrq)

    3.25

  • Enterprise Value/Revenue

    3.66

  • Enterprise Value/EBITDA

    9.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    30.65%

  • Return on Assets (ttm)

    9.40%

  • Return on Equity (ttm)

    25.01%

  • Revenue (ttm)

    8.65B

  • Net Income Avi to Common (ttm)

    2.65B

  • Diluted EPS (ttm)

    2.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.65B

  • Total Debt/Equity (mrq)

    16.12%

  • Levered Free Cash Flow (ttm)

    1.98B

Research Analysis: 002223.SZ

Analyst Price Targets

39.50
44.45 Average
36.88 Current
51.30 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: 002223.SZ

People Also Watch